Clinical Trial: Consortium for Optimized Integration of Bio-Artificial Blood Components for Adaptive Resuscitation Therapy
Study Status: Completed
Recruit Status: RECRUITING
Condition: Hemorrhage
Study Type: OBSERVATIONAL
Official Title: Consortium for Optimized Integration of Bio-Artificial Blood Components for Adaptive Resuscitation Therapy
Brief Summary:
There is need for a whole blood analog for use when banked blood is unavailable or undesirable.In civilian trauma, hemorrhage accounts for ~ 35% of pre-hospital deaths; moreover, ~ 20% of military casualties are in hemorrhagic shock on arrival to field hospitals and an additional 5% require urgent transfusion.A recent review concluded that hemorrhage accounted for ~ 90% of potentially survivable battlefield deaths - lives that could be saved with better hemorrhage control capabilities and improved, field-ready…
Read more